Prosecution Insights
Last updated: July 17, 2026
Application No. 18/114,066

SMOKING COMPOSITION COMPRISING FLAVOUR PRECURSOR

Final Rejection §103§112
Filed
Feb 24, 2023
Priority
Nov 22, 2013 — provisional 61/907,441 +4 more
Examiner
NGUYEN, PHU HOANG
Art Unit
1747
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Philip Morris International Inc.
OA Round
6 (Final)
66%
Grant Probability
Favorable
7-8
OA Rounds
6m
Est. Remaining
84%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
460 granted / 701 resolved
+0.6% vs TC avg
Strong +19% interview lift
Without
With
+18.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
52 currently pending
Career history
759
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
71.7%
+31.7% vs TC avg
§102
3.6%
-36.4% vs TC avg
§112
4.3%
-35.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 701 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 2-5 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the enablement requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to enable one skilled in the art to which it pertains, or with which it is most nearly connected, to make and/or use the invention. In the Appeal Brief Filed 9/30/2025, Appellant essentially argues that the combination of Robinson and Leffingwell list numerous compounds that can be used as flavour precursors (including glutathione) and do not link glutathione specifically to the production of furfurylthiol and it is not inherent to have a flavour precursor compound added to the aerosol forming substrate, wherein the flavor precursor compound releases a thiol-containing flavour compound upon heating of the aerosol forming substrate by the heating element and that the flavour precursor compound results in a production of furfurylthiol. This argument makes claims 2-5 failing to comply with the enablement requirement because the specification of the instant application states that preferably, the flavour precursor compound is cysteine or glutathione and more preferably, the flavour precursor compound is cysteine. Considering the factors according to MPEP 2164.01(a) including the breadth of the claims, nature of the invention, the state of the prior art and the level of one ordinary skill in the art. In this case the claimed invention is toward tobacco and a flavour precursor compound and the intended use of heating the tobacco and the flavour precursor compound results in a production of furfurythiol. Furthermore, the level of predictability in the art along with the direction provided by the inventor wherein the existence of working examples are glutathione or cysteine (the instant application publication discloses the flavour precursor compound is cysteine or glutathione [0045]). Therefore, based on the disclosure and working examples of the instant application specification, glutathione meets the claimed flavour precursor compound. However, further amount of direction provided by the inventor in the Appeal Brief filed 9/30/2025 wherein the Appellant states that it is not inherent to have a flavour precursor compound (including glutathione) added to the aerosol forming substrate, wherein the flavor precursor compound releases a thiol-containing flavour compound upon heating of the aerosol forming substrate by the heating element and that the flavour precursor compound results in a production of furfurylthiol. This further amount of direction provided by the inventor in the Appeal Brief filed 9/30/2025 seems to explicitly exclude glutathione from meeting the claimed flavour compound. In order for the claimed invention to be in compliance with the enablement requirement, glutathione must meet the claimed flavour precursor compound. For purpose of examination, the Examiner will assume that specification of the instant application is enable so that heating the preferred flavour precursor compounds such as cysteine and glutathione results in a production of furfurylthiol. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 2-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Robinson et al. (U.S Pub. No. 20080092912) in view of Leffingwell et al. (Tobacco Flavoring for smoking products 1972, pages 16 and 52). Regarding claim 2, Robinson discloses a smoking article comprising: an aerosol forming substrate comprising tobacco; a heating element configured to heat, but not combust, the aerosol forming substrate; a flavour precursor compound added to the aerosol forming substrate (Abstract [009] and [0058]); Robinson discloses a compound added to the aerosol forming substrate to release flavor upon heating but does not expressly disclose the compound release thiol-containing flavor compound upon heating. Leffingwell discloses using compounds such as glutathione (page 15) and furfuryl alcohol (page 16) in the smoking article as flavors. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to add glutathione/furfuryl alcohol to the smoking article of Robinson. Also, glutathione (the exact same compound identified by the Applicant) is known as a compound that releases a thiol-containing flavour compound upon heating, wherein heating of the aerosol forming substrate and glutathione results in the production of furfurylthiol (as admitted by the Applicant, lines 4-5 on page 6 of the specification of the instant application). Furthermore, Leffingwell also discloses furfuryl mercaptan (other name of the claimed furfurylthiol) are desired flavor for smoking article (page 52). Since glutathione is the same compound as the disclosed flavour precursor compound, one of ordinary skill in the art at the time the invention was made would expect it to meet the intended use limitation of releases a thiol-containing flavour compound (furfurylthiol) upon heating of the aerosol forming substrate by heating element. Regarding claim 3, glutathione/furfuryl alcohol are capable of releasing the flavour compound at a temperature overlapping with the claimed range of from about 200°C to about 450°C (as admitted by Applicant, table 5). Regarding claims 4-5, Robinson discloses the smoking article further comprising nicotine or a source of nicotine [0089]. Claim(s) 2-5 is/are rejected under 35 U.S.C. 103 as being unpatentable over Robinson et al. (U.S Pub. No. 20080092912) in view of Leffingwell et al. (Tobacco Flavoring for smoking products 1972, pages 16 and 52) and further in view of Binggeli et al. (U.S Pub. No. 20030165587) Regarding claim 2, Robinson discloses a smoking article comprising: an aerosol forming substrate comprising tobacco; a heating element configured to heat, but not combust, the aerosol forming substrate; a flavour precursor compound added to the aerosol forming substrate (Abstract [009] and [0058]); Robinson discloses a compound added to the aerosol forming substrate to release flavor upon heating but does not expressly disclose the compound release thiol-containing flavor compound upon heating. Leffingwell discloses using compounds such as mustard (page 57) and glutathione (page 15) and furfuryl alcohol (page 16) in the smoking article as flavors. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to add glutathione/furfuryl alcohol to the smoking article of Robinson. Also, glutathione and cystine (the exact same compound identified by the Applicant) is known as a compound that releases a thiol-containing flavour compound upon heating, wherein heating of the aerosol forming substrate and glutathione results in the production of furfurylthiol (as admitted by the Applicant, lines 4-5 on page 6 of the specification of the instant application). Leffingwell also discloses furfuryl mercaptan (other name of the claimed furfurylthiol) are desired flavor for smoking article (page 52). Binggeli discloses that heating mustard (Brassica within the family Brassicaceae) results in a production of furfurylthiol (Abstract). Alternatively, Robinson discloses a smoking article comprising: an aerosol forming substrate comprising tobacco; a heating element configured to heat, but not combust, the aerosol forming substrate; a flavour precursor compound added to the aerosol forming substrate (Abstract [009] and [0058]); Robinson discloses a compound added to the aerosol forming substrate to release flavor upon heating but does not expressly disclose the compound release thiol-containing flavor compound upon heating. Leffingwell discloses using compound such as furfuryl mercaptan (other name of the claimed furfurylthiol) are desired flavor for smoking article (page 52). Binggeli discloses heating precursor such as S-furfurylcysteine results in a production of furfurylthiol. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to use S-furfurylcysteine as the precursor compound that releases a thiol-containing flavour compound upon heating. The combination of Robinson, Leffingwell and Binggeli taken together as a whole teaches/suggests S-furfurylcysteine as the flavour precursor compound releases a thiol-containing flavour compound upon heating of the aerosol forming substrate by the heating element, wherein heating of the aerosol forming substrate and the flavour precursor compound results in a production of furfurylthiol. Regarding claim 3, glutathione/furfuryl alcohol are capable of releasing the flavour compound at a temperature overlapping with the claimed range of from about 200°C to about 450°C (as admitted by Applicant, table 5). Binggeli discloses the flavour precursor compound is configured to release the flavour compound at a temperature overlapping with the claimed range of temperature [0008]. Regarding claims 4-5, Robinson discloses the smoking article further comprising nicotine or a source of nicotine [0089]. Response to Arguments Applicant's arguments filed 3/31/2026 have been fully considered but they are not persuasive. Regarding the rejection under 35 U.S.C section 112, first paragraph, Applicant essentially argues that the Examiner has not established a reasonable basis for questioning the enablement of the pending claims because the Examiner failed to provide an analysis and conclusion of a lack of enablement based on the factors discussed in MPEP 2164.01(a) and the evidence as a whole. This argument is not persuasive because, the Examiner considered the factors according to MPEP 2164.01(a) including the breadth of the claims, nature of the invention, the state of the prior art and the level of one ordinary skill in the art. In this case the claimed invention is toward tobacco and a flavour precursor compound and the intended use of heating the tobacco and the flavour precursor compound results in a production of furfurythiol. Furthermore, the level of predictability in the art along with the direction provided by the inventor wherein the existence of working examples are glutathione or cysteine (the instant application publication discloses the flavour precursor compound is cysteine or glutathione [0045]). Therefore, based on the disclosure and working examples of the instant application specification, glutathione meets the claimed flavour precursor compound. However, further amount of direction provided by the inventor in the Appeal Brief filed 9/30/2025 wherein the Appellant states that it is not inherent to have a flavour precursor compound (including glutathione) added to the aerosol forming substrate, wherein the flavor precursor compound releases a thiol-containing flavour compound upon heating of the aerosol forming substrate by the heating element and that the flavour precursor compound results in a production of furfurylthiol. This further amount of direction provided by the inventor in the Appeal Brief filed 9/30/2025 seems to explicitly exclude glutathione from meeting the claimed flavour compound. In order for the claimed invention to be in compliance with the enablement requirement, glutathione must meet the claimed flavour precursor compound. Regarding the rejection under 35 U.S.C section 103, Applicant essentially argues that the Examiner has not identified any support in the cited references demonstrating the intended use limitation wherein the production of furfurylthiol (a thiol-containing compound) is a result of heating of the aerosol forming substrate by the heating element. This argument is not persuasive because the combination of Robinson and Leffingwell taken together as a whole discloses an aerosol forming substrate comprising tobacco, a heating element configured to heat, but not combust, the aerosol forming substrate; and a flavour precursor compound (glutathione); one of ordinary skill in the art at the time the invention was made would expect the intended use limitation of heating the aerosol forming substrate and the flavour precursor compound (glutathione) results in a production of furfurylthiol. Applicant again asserts that it is not inherent that heating glutathione or furfuryl alcohol results in the production of furfurylthiol. This assertion is similar to the assertion in the Appeal Brief filed 9/30/2025 that put the claimed invention’s compliance with the enablement requirement as discussed above. Applicant also argues that Leffingwell discloses furfuryl alcohol and glutathione exhibit different smoke tastes and aromas from furfurylthiol thereby indicating that heating glutathione does not necessarily result in the production of furfurylthiol. This argument is not persuasive because the Examiner does not take the position that glutathione (precursor compound) is furfurythiol (same tastes aroma); rather, the combination of Robinson and Leffingwell taken together as a whole discloses an aerosol forming substrate comprising tobacco, a heating element configured to heat, but not combust, the aerosol forming substrate; and a flavour precursor compound (glutathione); one of ordinary skill in the art at the time the invention was made would expect the intended use limitation of heating the aerosol forming substrate and the flavour precursor compound (glutathione) results in a production of furfurylthiol. Applicant also argues that a person of ordinary skill in the art would not have been motivated to combine Leffingwell and Robinson for the intended use of generating furfurylthiol upon heating with aerosol forming substrate. This argument is not persuasive because Leffingwell discloses glutathione, furfuryl alcohol and furfurythiol are all desired compound for a smoking article. Furthermore, as explained above, one of ordinary skill in the art at the time the invention was made would expect the intended use limitation of heating the aerosol forming substrate and the flavour precursor compound (glutathione) results in a production of furfurylthiol. Regarding the rejection based on Robinson in view of Leffingwell and further in view of Binggeli, the Examiner relied on Binggeli for the intended use limitation of heating the flavor precursor compound results in a production of furfurylthiol. Applicant essentially argues that the Binggeli does not expressly disclose using S-furfurylcysteine independently from a Brassica seed as a precursor in a different system; therefore, a person of ordinary skill in the art would not be motivated to use S-furfurylcysteine as a flavour precursor independent of a Brassica seed as a flavour precursor compound added to the aerosol forming substrate. This argument is not persuasive because, as Applicant pointed out, Binggeli identifies the FFT-precursor (S-furfurylcysteine) within the Brassica seed chemically react upon heating the seed, thereby forming FFT [0018]. It would be clear that one of ordinary skill in the art would have a reasonable expectation of success that heating S-furfurylcysteine (FFT-precursor compound) results in a production of furfurylthiol (FFT) according to the disclosure of Binggeli. Furthermore, since Leffingwell also discloses mustard (Brassica seed) as a desired flavouring compound for a smoking article (page 57); the combination of Robinson, Leffingwell and Binggeli discloses the production of furfurylthiol exactly like the disclosure of Binggeli and meets the claimed invention. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHU H NGUYEN whose telephone number is (571)272-5931. The examiner can normally be reached M-F 9-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael H Wilson can be reached at 5712703882. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHU H NGUYEN/Examiner, Art Unit 1747
Read full office action

Prosecution Timeline

Show 10 earlier events
Apr 03, 2025
Response Filed
Jun 03, 2025
Final Rejection mailed — §103, §112
Sep 02, 2025
Notice of Allowance
Sep 30, 2025
Response after Non-Final Action
Oct 13, 2025
Response after Non-Final Action
Jan 09, 2026
Non-Final Rejection mailed — §103, §112
Mar 31, 2026
Response Filed
Jun 24, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12677868
SMOKING ARTICLE
1y 10m to grant Granted Jul 14, 2026
Patent 12660845
APPARATUS AND METHOD FOR FILLING SMOKING CONES
3y 1m to grant Granted Jun 23, 2026
Patent 12653969
LEAK-RESISTANT VAPORIZER DEVICE
2y 0m to grant Granted Jun 16, 2026
Patent 12648590
HARM-REDUCING CIGARETTE FILTER, PREPARATION METHOND AND APPLICATION THEREOF
2y 9m to grant Granted Jun 09, 2026
Patent 12642294
AEROSOL GENERATING ARTICLE COMPRISING COMBUSTIBLE HEAT SOURCE
3y 8m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
66%
Grant Probability
84%
With Interview (+18.9%)
3y 10m (~6m remaining)
Median Time to Grant
High
PTA Risk
Based on 701 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month